Reversion Agreement. Except with respect to a termination of this Agreement by BMS pursuant to Section 11.3 (Termination for Cause) or by BMS pursuant to Section 11.2 (Termination at Will) as a result of a Safety Concern, at Avidity’s request in writing (“Reversion Notice”), the Parties will negotiate in good faith and enter into a written agreement (“Reversion Agreement”) pursuant to which: [***].
Appears in 2 contracts
Sources: Research Collaboration and License Agreement (Atrium Therapeutics, Inc.), Research Collaboration and License Agreement (Avidity Biosciences, Inc.)